Latest Breaking News On - Iteos therapeutics inc 39 s - Page 1 : vimarsana.com

Development of a new cancer immunotherapy pioneered by Roche was thrown in doubt on Wednesday when its drug tiragolumab failed to slow the progression of lung cancer in a second trial.

Junshi biosciencesBristol myers squibbTeos therapeutics incGilead sciencesMerck coAgenus incArcus biosciencesMyers squibbShanghai junshi biosciencesCancer immunotherapy prospectsAnti tigitMerck amp coCoherus biosciencesAgenus inc 39 sLudwig burgerJohn revill